Group items tagged

Disini saya akan memberikan sebuah Cara Mengatasi Linu Bagian Kaki yang sudah dijamin cepat dalam proses penyembuhan, aman tanpa khawatir menimbulkan efek samping. Yaitu dengan mengkonsumsi sebuah produk Herbal Ricalinu yang diproduksi oleh Herbalindso SM Indonesia dengan Legal POM TR No. 062262321 dan sudah dipastikan HALAL untuk dikonsumsi.

Banyak sekali diluaran saya yang menjual produk herbal sebagai Cara Mengatasi Pegal Linu Tanpa Efek Samping tapi tidak ada khasiatnya sama sekali. Tetapi disini anda tidak perlu khawatir. Karena produk Herbal yang kami rekomendasikan adalah RICALINU yang sudah terbukti efektif, ampuh, cepat dalam proses pengobatan dan dipastikan HALAL untuk dikonsumsi dengan Legal POM TR No. 062 262 321

The Pharmacists' Defence Association (PDA) has begun conciliation with 86 pharmacy companies to safeguard the interests of former LloydsPharmacy pharmacists. The Advisory, Conciliation and Arbitration Service (Acas), a government agency, serves as a mediator between companies and employees to resolve disputes. If the ongoing mediation prove unsuccessful, individual employees retain the option to file claims in the employment tribunal, the PDA has said. The ongoing dispute centres around employers potentially failing to conduct the required consultation under the Transfer of Undertakings (Protection of Employment) regulations (TUPE) with employees and their representatives during employee transfers, the PDA said. The TUPE legislation, known for its complexity and technical nature, applies when a section of the company, like a pharmacy sold as an asset using standard disposal, undergoes a transfer. According to NHS England's recent pharmaceutical list, LloydsPharmacy has either sold or shuttered 461 branches since September 2022. According to NHSE data, as of June 30, the pharmacy chain operates approximately 512 pharmacies in England. This positions it as the third-largest chain after Boots UK and Well Pharmacy.

In a recent minute of meeting, the General Pharmaceutical Council (GPhC) explored the implications of its unique authority under the Regulation of Investigatory Powers Act (RIPA), granting powers for covert surveillance. Although never utilized, the GPhC is obligated to maintain appropriate policies for such actions. During a recent meeting, the pharmacy regulator discussed that the use of RIPA be brought to a future Council workshop to discuss issues including the "ethical implications of having and using the powers, the possible use of RIPA in online pharmacy investigations and retaining the powers to deal with future scenarios as yet unknown". Led by Chief Executive and Registrar, Duncan Rudkin, the discussion underscored the importance of having robust oversight mechanisms in place. The inspection report provided assurance that the GPhC's policies align with regulatory requirements.